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The objective of this research was to identify the effects of 3-week treatment of normal and streptozotocin-
induced diabetic rats using a leaf decoction of Campomanesia xanthocarpa Berg. (20 g/L) on 
physiological, biochemical and histological parameters. Streptozotocin (STZ, 70 mg/kg in citrate buffer, 
pH 4.5) was administered IP to induce experimental diabetes one week prior to the treatment. STZ caused 
typical diabetic symptoms: polydypsia, polyuria, polyphagia, hyperglycemia, hypertriglyceridemia and 
histopathological modifications in the pancreas, liver and kidney. The treatment of diabetic rats using 
the decoction decreased blood glucose levels, inhibited hepatic glycogen loss, and prevented potential 
histopathological alterations in the pancreas and kidneys. No differences were found between the control 
rats treated with the decoction and the control rats maintained on water only. In conclusion, these results 
suggest that C. xanthocarpa leaf decoction (20g/L) might be useful for diabetes mellitus management, 
but further pharmacological and toxicological studies are needed.
Uniterms: Campomanesia xanthocarpa/pharmacognosy. Diabetes Mellitus/experimental study. 
Hypoglycemic plant. Histology. Carbohydrate/metabolism. Lipid/metabolism.
O objetivo deste trabalho foi identificar os efeitos do tratamento com o decocto das folhas de Campomanesia 
xanthocarpa Berg. (20 g/L), durante 3 semanas, sobre parâmetros fisiológicos, bioquímicos e histológicos 
de ratos normais e diabéticos induzidos por estreptozotocina. O diabete melito foi induzido uma semana 
antes de iniciar o tratamento experimental, pela administração IP de estreptozotocina (STZ, 70 mg/
kg em tampão citrato, pH 4.5). Os ratos tratados com STZ apresentaram sintomas típicos de diabete: 
polifagia, polidipsia, hiperglicemia, hipertrigliceridemia e alterações histopatológicas no pâncreas, 
fígado e rim. O tratamento dos ratos diabéticos com o decocto diminuiu os níveis de glicose sanguínea, 
inibiu a degradação do glicogênio hepático e preveniu possíveis alterações histopatológicas no pâncreas 
e no rim. Nos ratos controles tratados com o decocto não foram verificadas diferenças significativas em 
relação aos controles tratados com água. Em conclusão, os resultados sugerem que o tratamento com 
o decocto das folhas de C. xanthocarpa leaf decoction (20 g/L) possa ser útil para o manejo do diabete 
melito, porém estudos farmacológicos e toxicológicos ainda são necessários.
Unitermos: Campomanesia xanthocarpa/farmacognosia. Diabete Melito/estudo experimental. Planta 
hipoglicemiante. Carboidratos/metabolismo. Lipídeos/metabolismo.
INTRODUCTION
More than 170 million people are affected by dia-
betes worldwide, an incidence estimated to rise 50% by 
2030, with the greatest increases set to occur in the devel-
oping countries of Africa, Asia and South America (WHO, 
2008). In Brazil, 7.6 % of the population aged between 30 
and 69 years has diabetes, with the cities of São Paulo and 
Porto Alegre registering the highest percentages: 9.7 and 
8.9 %, respectively (Salgado, 1998). Diabetes mellitus is a 
chronic metabolic disease characterized by hyperglycemia 
and disturbances in carbohydrate, fat and protein metabo-
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lism. It is associated with an absolute or relative deficiency 
in the secretion of insulin (Diabetes Mellitus 1, DM1) 
or with insulin resistance (Diabetes Mellitus 2, DM2) 
(Savage et al., 2007; Stumvoll et al., 2005). DM2 is the 
most common form of the disease, accounting for 85 to 
90% of all recorded cases (Tiwari, Rao, 2002). Besides 
hyperglycemia, hyperlipidemia is involved in the develop-
ment of the micro and macro vascular complications of di-
abetes, which are the major causes of morbidity and death 
(Tang et al., 2006). Despite the great efforts made to better 
understand and manage this disease, serious problems such 
as retinopathy, nephropathy and lower extremity amputa-
tion continue to affect patients, while diabetes-related 
mortality is rising unabated (Tiwari, Rao, 2002). Insulin 
resistance can also lead to Metabolic Syndrome (MS), 
a complex metabolic disease characterized by obesity, 
hypertension, dyslipidemia and DM2 (Sanchéz-Salgado 
et al., 2007). The current rise in DM2 and MS is believed 
to be a result of an increase in the sedentary life styles 
combined with ready access to energy-rich food sources 
in genetically susceptible individuals (Savage et al., 2007).
Treatment of diabetes involves diet control, exercise 
and the use of hypoglycemic or lipid-lowering drugs such 
as insulin, sulphonylureas, biguanides and thiazolinedio-
nes (Stumvoll et al., 2005). However, many oral medi-
cines have a number of serious adverse effects, and the 
management of hyperglycemia and hyperlipidemia with 
low side effects is still a challenge for the medical system 
(Revilla-Monsalve et al., 2007). Another problem faced 
is the cost of the treatment, which is often prohibitively 
high in developing countries (Schoenfelder et al., 2006). 
In Brazil, some 200 plants are popularly used for the ma-
nagement of diabetes (Barbosa-Filho et al., 2005). Such 
plants are used in formulations of home-made medicines 
such as teas, decoctions and tinctures (Schoenfelder et al., 
2006). The main phytochemicals described as useful for 
treating diabetes are terpenoids, coumarines, flavonoids, 
alkaloids, phenolic substances and lecitines (Barbosa-
Filho et al., 2005).
Campomanesia xanthocarpa Berg., popularly 
known as gabiroba, is a common species in the forests of the 
Southern, Southeastern and Midwestern regions of Brazil, 
and is also found in Uruguay, Paraguay and Argentina. The 
infusion prepared from its leaves is commonly used as a 
depurative, anti-diarrheic, cleanser, anti-rheumatic, and 
to lower blood cholesterol (Ballvé et al., 1995). Recently, 
Dickel et al. (2007) confirmed that it is popularly used to 
reduce obesity by the population of Porto Alegre, in the 
southern region of Brazil. Despite its popular use, there is 
scant pharmacological information available on this plant. 
Markman et al. (2004) described the anti-ulcerogenic 
activity of the alcoholic extract and Fernandes and Vargas 
(2003) demonstrated mutagenic and anti-mutagenic poten-
tial. The chronic treatment of obese rats with the infusion 
of the leaves of C. xanthocarpa led to a significant decrease 
in body mass, as well as a reduction in glycemia (Biavatti 
et al., 2004). Since C. xanthocarpa caused a hypoglycemic 
effect in obese rats, the objectives of this research were to 
verify the effects of the chronic treatment of normal and 
streptozotocin-induced diabetic rats using a leaf decoction 
of C. xanthocarpa (20 g/L) on physiological, biochemical 
and histopathological parameters.
MATERIAL AND METHODS
Plant material
Campomanesia xanthocarpa leaves were collected 
in Gravataí, Rio Grande do Sul State, Brazil, and were 
identified by Dr. Sérgio Bordignon. An exsiccate (vou-
cher specimen) was deposited in the Herbarium of the 
Lutheran University of Brazil (ULBRA) under the code 
1715. The leaves were kept in a dry and ventilated place, 
protected from light, and were dried and powdered. The 
decoct (20 g/L) was prepared daily, boiled for 10 minutes 
and when reaching room temperature, the solution was 
filtered and administered to the rats as a drinkable solution. 
Rats and experimental design
Male Wistar rats weighing 164.97 ± 11.69 g (mean 
± SEM, n= 70), bred at our animal facility, were used in 
this study. The rats were housed in an environmentally-
controlled room with a 12 h light: 12 h dark cycle (lights 
on at 7:00 am) at a constant temperature of 23 °C. All the 
experimental procedures were carried out in accordance 
with the guidelines of the Brazilian College of Animal 
Experimentation (COBEA), and the experimental protocol 
was approved by the Research Ethics Committee of the 
Lutheran University of Brazil and registered under the 
number 2004-024A.
A freshly-prepared solution of streptozotocin (STZ, 
70 mg/kg/bw) in 0.1 M citrate buffer, pH 4.5 was injected 
intraperitoneally to rats that had fasted overnight (Kesari 
et al., 2007). One week later, blood samples were collected 
from the orbital sinus, and rats with fasting blood glucose 
(FBG) levels above 200 mg/dL (11.1 mmol/L) were se-
lected for the experimental protocol.
During a 21-day period of treatment, normal and 
STZ-treated rats were fed with 40 g/day of pelleted food 
(Nuvital, Nuvilab CR1, Curitiba, PR, Brazil) and divided 
into four drinking groups:
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-  Group I (WC): water (negative) control; control rats 
which received 100 mL of water a day (n=15).
-  Group II (WD): water (untreated) diabetic; STZ-
treated rats which received 100 mL of water a day 
(n=16).
-  Group III (DC): decoct (positive) control; control 
rats which received 100 mL of C. xanthocarpa 
(20 g/L) decoction a day (n=19).
-  Group IV (DD): decoct diabetic; STZ-treated rats 
which received 100 mL of C. xanthocarpa (20 g/L) 
decoction a day (n=19).
At the end of the second week of treatment, the rats 
were transferred to individual metabolic cages where they 
were kept for a further week. During this period, the total 
amount of food and drink ingested were measured daily, 
as was urine volume. Throughout the experimental period, 
blood samples were collected weekly from the eyes (venous 
pool) under mild ether anesthesia (30 seconds of exposure) 
and collected in Eppendorfs with 0.1 mL of sodium citrate as 
anti-clotting agent. After centrifugation, the plasma samples 
were stored frozen for later biochemical analysis. 
On the last day of the treatment, after a 12-hour 
period of fasting, the rats were sacrificed by decapitation 
after mild ether anesthesia. Blood and organ samples (liver, 
diaphragm, kidney and pancreas) were collected. The blood 
samples were obtained by means of heart puncture with 0.1 
mL of sodium citrate. After centrifugation, the plasma was 
separated and stored frozen for the subsequent biochemical 
assays. The body weight of the rats was also monitored.
Biochemical analysis
Blood glucose was determined by the glucose oxi-
dase method using glucose diagnostic kits HK-Liquiform 
(Labtest Diagnóstica). Plasma triglycerides and total 
cholesterol were also determined using diagnostic kits: 
Triglycerides GPO-ANA (Labtest Diagnóstica) and 
cholesterol-liquiform (Labtest Diagnóstica).
Liver samples used for glycogen determination were 
collected using the freeze-clamp procedure with aluminum 
tongs and stored frozen. The glycogen extraction followed 
the method of van Handel (1965) and the values were de-
termined as glucose equivalents after acid hydrolysis (HCl) 
and neutralization (Na
2
CO
3
), according to the method of 
Geary et al. (1981). The results obtained were expressed 
as mg/g of tissue.
Histological analysis
For the histopathological analysis, samples of 
the liver, pancreas and kidney were preserved in 10% 
formaldehyde for 24 hours and processed following the 
routine procedure described by Tolosa et al. (2003): the 
tissues were blocked in Histosec and serial slices (7 µm-
thick) were obtained using a Microtome (Microtome RM 
2025), stained with hematoxylin-eosin, and analyzed 
under an optical microscope (Leica CME). Pancreas 
samples were also stained with Gomori’s aldehyde-
fuchsin, a procedure for identifying the effects of the 
treatments on β cells (Tolosa et al., 2003; Diani et al., 
2004). Photographs were taken using a digital camera 
(SONY DSC-W1) attached to the microscope.
Statistical analysis
The results were expressed as mean ± S.E.M. 
(standard error). Comparisons were made using one-way 
ANOVA followed by Duncan’s and Bonferroni’s post-hoc 
tests. In all comparisons, values of p < 0.05 were conside-
red statistically significant. Statistical tests were performed 
using the SPSS program (Statistical Package for Social 
Sciences, version 10.0, for Windows). 
RESULTS AND DISCUSSION
Physiological results
The difference between the final and initial weights 
of the rats is shown in Table I. In the control groups, 
the total body weight of the rats increased, while this 
weight gain was lower in the diabetic groups (p > 0.05). 
The hepatosomatic index (HI) represents the weight 
of the liver in relation to total body weight (Table I) 
and no significant difference (p > 0.05) was detected 
in HI among the experimental groups. The amount of 
food ingested during the last week of treatment (Ta-
ble I) increased significantly (p < 0.05) in the control 
group treated with C. xanthocarpa decoct, as well as 
in both diabetic groups (WD and DD) compared to the 
untreated control group. The volume of liquid ingested 
and the urinary flux of both diabetic groups increased 
(p < 0.05) in relation to the two control groups. In the 
present study, STZ induced typical signs of diabetes 
including reduced weight gain, polyphagia, polydypsia 
and polyuria, (Cavalli et al., 2007; Dobrzynski et al., 
2002). It is interesting to note that the C. xanthocarpa 
decoction had no diuretic effect in the control or diabetic 
groups, a common side effect of many teas and herbal 
infusions. The final ingested dose of C. xanthocarpa de-
coct was 0.737 g/mL for the control rats and 1.65 g/mL 
for the diabetic rats. 
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Biochemical results
One week after the administration of streptozotocin, 
the levels of plasma glucose (Figure 1) had significantly 
increased (p < 0.05) in both groups of STZ-treated rats 
in relation to the control groups. Only those rats with 
blood glucose above 13.875 mmol/L (250 mg/dL) were 
considered diabetic. Neither of the control groups sho-
wed any significant variation in blood glucose during the 
experiment (p > 0.05). At the end of the treatment, the 
diabetic rats that received C. xanthocarpa decoct showed 
a 26 % reduction in blood glucose (p < 0.05) in relation 
to the untreated diabetic group. This finding is in agree-
ment with the description of Biavatti et al. (2004), which 
reported a 15 % reduction in the plasma glucose level of 
obese rats (induced with a hypercaloric diet) treated with 
C. xanthocarpa. In other pharmacological investigations 
involving hypoglycemic plants, a 12 to 20 % reduction in 
blood glucose level was considered significant (Sánchez-
Salgado et al., 2007 and Cavalli et al., 2007). In the control 
rats treated with C. xanthocarpa, blood glucose levels 
displayed no significant variation. According to Kesari et 
al. (2007), this is also a relevant result, demonstrating that 
continuous use of the decoct will not result in hypoglyce-
mic shock, usually the case when insulin or sulfonylurea 
drugs are taken in excessive doses.
The values of total cholesterol (Table II) in the plas-
ma of all tested groups displayed no significant alteration 
(p > 0.05) during the experimental period. However, in 
both diabetic groups, blood triglycerides levels (Table II) 
had increased significantly (p < 0.05) in relation to the 
untreated control group by the end of the experimental 
period. The levels of serum lipids are usually high in diabe-
tes mellitus, where such elevation represents a risk factor 
for coronary heart disease (Kesari et al., 2007; Pushparaj 
et al., 2007; Savage et al., 2007). This abnormally high 
level of serum lipids is mainly due to the uninhibited 
action of lipolytic hormones on fat deposits (Pushparaj 
et al., 2007; Savage et al., 2007). Hypercholesterolemia 
and hypertriglyceridemia may also occur in STZ-treated 
rats (Pushparaj et al., 2007). In the present study, only tri-
glycerides displayed a significant increase in STZ treated 
rats, whereas C. xanthocarpa decoct caused no significant 
variation in triglyceride levels. This finding is in line with 
the description of Biavatti et al. (2004), which reported no 
significant effects of C. xanthocarpa on the lipid levels of 
rats fed with a hypercaloric diet. This result suggests that 
the popular use of C. xanthocarpa as an anti-obesity treat-
ment (Dickel et al., 2007) should not be encouraged until 
further pharmacological studies have been undertaken.
The levels of glycogen in the liver at the end of the 
treatment are shown in Table II. The untreated diabetic 
rats displayed a 36 % reduction (p < 0.05) in hepatic 
glycogen in relation to the untreated control group. On 
the other hand, the hepatic glycogen levels of the diabetic 
TABLE I - Physiological parameters of control and diabetic rats treated with the decoct of C. xanthocarpa or water. ΔW: Weight 
gain, difference between the final and initial weights of the rats. The values are expressed as mean ± S.E.M.
Treatment Water Control  C. xanthocarpa Control Water Diabetic C. xanthocarpa Diabetic
ΔW(g) 156.20±15.06 176.141±16.83 53.573±17.68* 26.74±11.55*
Hepatosomatic Index 3.22 ± 0.16 3.23 ± 0,15 2.99 ± 0.17 3.03 ± 0.14
Ingested Food (g/day) 21.61 ± 0.46 25.46 ± 0.25* 30.03 ± 0.29*a 34.76 ± 0.24*a
Ingested Drink (mL/day) 38.03 ± 2.29 36.85 ± 1.99 84.92 ± 4.44* 82.59 ± 1.06*
Urine (mL/day) 7.20 ± 2.39 7.16 ± 2.38 39.11 ± 1.2* 42.02 ± 1.55*
*: Statistically significant difference compared to water control group (p < 0.05). 
a: Statistically significant difference compared to decoct control group (p < 0.05). 
FIGURE 1 - Plasma glucose levels (mmol/L) of control and 
diabetic rats treated with decoct of C. xanthocarpa or water. 
WC: control rats treated with water; DC: control rats treated 
with decoct; WD: diabetic rats treated with water; DD: diabetic 
rats treated with decoct. Columns represent means, and bars 
represent S.E.M. *: Statistically significant difference compared 
to water control group (p < 0.05). #: Statistically significant 
difference compared to water diabetic group (p < 0.05).
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rats treated with C. xanthocarpa decoct were similar to 
those of the untreated control group (p > 0.05). The liver 
plays a pivotal role in maintaining energy homeostasis 
during feeding/fasting transitions. While the peripheral 
tissues, predominantly skeletal muscle, account for the 
majority of the postprandial insulin-stimulated glucose 
disposal, the liver also plays a key role in buffering inges-
ted carbohydrate by suppressing hepatic glucose output 
and stimulating glucose deposition as liver glycogen. 
In the fasting state, hepatic glycogen stores are rapidly 
mobilized to maintain circulating glucose concentrations, 
representing around 50 % of endogenous glucose produc-
tion in the first hours of fasting, while gluconeogenesis 
accounts for the remaining 50% (Savage et al., 2007). 
In this study, the untreated diabetic rats displayed a 36% 
reduction in hepatic glycogen in relation to the untrea-
ted control group, a common feature of diabetes. In the 
diabetic state, the absence of insulin leads to decreased 
liver glycogen synthesis which enhances plasma glucose 
levels. In addition, glucagon levels are high in this con-
dition, stimulating glycogenolysis and gluconeogenesis, 
and resulting in reduced liver glycogen (Jhiang, Zhang, 
2003). Thus, the reduced glycogen levels in diabetic pa-
tients can be explained by reduced glycogen synthesis, 
and also by an increase in glycogenolysis and gluconeo-
genesis (Ferreira et al., 2001; Grover et al., 2002; Savage 
et al., 2007). On the other hand, hepatic glycogen of the 
diabetic rats treated with C. xanthocarpa decoct was si-
milar to the untreated control group, suggesting that this 
treatment was able to restore or preserve liver glycogen. 
A similar effect was reported by Grover et al. (2002) in 
diabetic mice (STZ induced) treated with Eugenia jam-
bolana (200 mg/kg/day). These authors stated that this 
effect can be explained by a possible stimulatory effect 
of the extract on insulin release from β cells, either by 
the insulinomimetic action of a component present in the 
extract, or by a combination of the two processes. More 
recently, Oliveira et al. (2008) reported an increase in 
liver glycogen in STZ-diabetic rats treated with Vatairea 
macrocarpa extract.
Histopathological results
Representative photomicrographs from the HE-
stained tissue sections are shown in Figures 2 and 3. The 
pancreatic islets from both control groups displayed nor-
mal histological features: the islets are oval (Figure 2A) 
and spread throughout the exocrine structures, the acinis. 
This finding is in agreement with the description of Tang et 
al. (2006). The Gomori stain (Figures 2B and 2C) demons-
trates that β cells are found mainly in the central region 
of the islets, while some are in the peripheral region. The 
cytoplasm of these cells displays green stain, confirming 
the presence of insulin granules, as described by Diani et 
al. (2004). In the untreated diabetic rats (Figure 2D), the 
islets have shrunk: they have a reduced diameter and irre-
gular shape, with a small number of cells and vacuolization 
of the cytoplasm. The same pattern was described by Tang 
et al. (2006). The Gomori stain (Figure 2E) did not display 
green stain, indicating the absence of insulin granules, in 
accordance with the description of Diani et al. (2004). In 
the diabetic group treated with the decoction (Figure 2F) 
the shape of the islet is not as irregular, and green stains 
are present, indicating the presence of insulin. This finding 
suggests that the treatment of STZ-diabetic rats with C. 
xanthocarpa decoction can reduce some of the damage 
induced by STZ. According to Tiwari and Rao (2002), it 
is practically impossible to regenerate β cells once they 
are destroyed. However, the crude extract of Pterocar-
pus marsupium, an Ayurvedic medicinal plant, has been 
reported to confer protective and restorative effects on 
alloxan-induced diabetic rats. These results were reported 
through histological observations, together with a notable 
improvement in blood sugar levels. Another medicinal 
plant reported to have beneficial effects on islet morpholo-
gy is the bitter melon Momordica charantia (Ahmed et al., 
1998). A recent histological analysis of alloxan-induced 
diabetic rats treated with berberine, the main active cons-
tituent of Rhizoma coptidis, showed that it was able to 
alleviate the progression of diabetes (Tang et al., 2006). 
According to these authors, the mechanism of action of 
TABLE II - Biochemical parameters in plasma and liver of control and diabetic rats treated with decoct of C. xanthocarpa or water. 
Values are expressed as mean ± S.E.M. 
Treatment Water Control C. xanthocarpa Control Water Diabetic C. xanthocarpa Diabetic
Total Cholesterol (mmol/ L) 1.016 ± 0.078 1.225 ± 0.121 1.074 ± 0.067 1.075 ± 0.108
Triglycerides (mmol/ L) 0.442 ± 0.040 0.575 ± 0.060 0.684 ± 0.079* 0.690 ± 0.068*
Liver Glycogen (mg/g of tissue) 147.93 ± 20.19 123.10 ± 20.20 95.43 ± 15.89* 130.78 ± 27.30
*: Statistically significant difference compared to water control group (p < 0.05). 
a: Statistically significant difference compared to decoct control group (p < 0.05). 
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berberine remains unclear, but effects may be related to 
its ability to scavenge free radicals. The damage induced 
in β cells by STZ in rats can also be slowed or prevented 
by treatment with thiazolinediones (rosiglitazone, trogli-
tazone or pioglitazone) in the early stages of the disease 
(Diani et al., 2004; Higa et al., 1999). The prevention of 
β cell destruction by thiazolinediones is linked to their 
anti-inflammatory action on glucose-mediated IL-1β, as 
well as to their ability to decrease islet triglyceride con-
tent, which if left untreated, generates nitric oxide leading 
to both diminished islet cell viability and mitochondrial 
biogenesis (Diani et al., 2004).
The liver of the control rats (Figure 3A) presented 
typical histological organization, matching the description 
of Teckman et al. (2002). In control rats treated with C. 
xanthocarpa decoction, the liver also displayed typical his-
tological organization, except for an inflammatory process 
in the stroma and hypertrophic nuclei in some of the he-
patocytes. In both groups of diabetic rats, the hepatocytes 
were enlarged, with vacuolar cytoplasm and hypertrophic 
nuclei. The stroma displayed discreet disorganization with 
enlargement of the space between the hepatocyte plaques, 
sinusoidal dilatation, and an infiltrative inflammatory 
process in the periportal region (Figure 3B). These results 
indicate that the treatment with C. xanthocarpa decoct was 
unable to prevent these morphological alterations in the 
liver. Further histopathological and toxicological studies 
are necessary in order to better evaluate the effects of C. 
xanthocarpa on the liver.
FIGURE 2 - Photomicrographs (400X) showing effects 
of different treatments on histopathological parameters of 
pancreatic islets. A: Photomicrograph of normal pancreatic islet 
from water control group, islets cells (thin arrow), conjunctive 
tissue (large arrow), HE stained. B: Photomicrograph of normal 
pancreatic islet from water control group, Gomori-stained, 
showing insulin granules (green spots) within β cells (thin 
arrow), conjunctive tissue (large arrow). C: Photomicrograph 
of normal pancreatic islet from decoct treated control group, 
Gomori-stained displaying insulin granules within β cells 
(arrow). D: Pancreatic islet from untreated diabetic group 
displaying altered shape and cytoplasmatic vacuolization 
(arrow), HE stained. E: Pancreatic islet from untreated 
diabetic group stained with Gomori, displaying altered shape, 
cytoplasmatic vacuolization (arrow) and absence of β cells, 
400X. F: Pancreatic islet from diabetic group treated with 
decoct, Gomori-stained, displaying less altered shape and 
presence of β cells with insulin granules (arrow). 
F IGURE 3  -  Effects  of  the  di fferent  t reatments  on 
histopathological parameters of liver and kidneys: A: Normal 
liver from water control group, HE-stained, showing portal 
triad, 250X. B: Liver from diabetic animal with inflammatory 
process in the portal triad and enlarged stroma (arrow), 250X. 
C: Kidney from diabetic rat treated with water displaying altered 
glomerular morphology, inflammatory process in renal papilla 
(large arrow) and dilatation of tubules (thin arrow), 400X. 
D: Kidney with concentric fibrosis from diabetic rat treated 
with water (arrow), 400X. E: Kidney with normal glomerular 
morphology (arrow) from diabetic rat treated with decoct, 400X. 
H: Fibrotic scar (arrow) in renal cortex of diabetic rat treated 
with decoct, 250X. 
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In both groups of control rats, the kidney presen-
ted a typical histological structure. In the kidneys of the 
untreated diabetic rats (Figure 3C), many pathological 
alterations were found: partial cellular lesion with aci-
dophilic material in the glomerulus, concentric fibrosis 
with distortion of the tubular wall and enlargement of 
the tubular lumen (Figure 3D), vacuolization of the cyto-
plasm of the tubular epithelium cells; atypical nuclei, and 
inflammatory processes in the interstitial spaces in renal 
papilla and pelvis regions. These alterations are typical of 
diabetic nephropathy (Thorup et al., 2000). The diabetic 
rats treated with C. xanthocarpa decoction displayed no 
glomerular or tubular pathological alterations (Figure 3E). 
Inflammatory processes were absent, but fibrotic scars 
were found (Figure 3F). These findings suggest that treat-
ment with C. xanthocarpa may have an anti-inflammatory 
effect on the kidneys.
In summary, in the present study, STZ was able to 
induce typical signs of diabetes, such as weight reduction, 
polyphagia, polydypsia, polyuria, hyperglycemia, reduced 
hepatic glycogen levels and nephropathy. Treatment of 
the STZ rats with C. xanthocarpa decoction significantly 
reduced their glycemic levels, restored hepatic glycogen 
levels, and produced favorable histopathological results, 
preserving the pancreatic islets and the kidneys. Moreover, 
the decoction of C. xanthocarpa had no diuretic effect in 
the control or diabetic groups, where diuresis is a common 
side effect of many teas and herbal infusions.
The presence of quercetin, myricetin, quercitrin 
and rutin in the decoct of C. xanthocarpa was reported 
by Schmeda-Hirschmann (1995). This phytochemical 
profile suggests that flavonoids (probably quercetin) 
may be responsible for the effects of this decoction. The 
antioxidant quercetin may act on STZ-induced diabetic 
rats in a number of ways. It may help by improving the 
secretion of insulin or by increasing the glucose uptake by 
the tissues (Broadhurst et al., 2000). Another study showed 
that quercetin, at doses of 10–50 mg/kg body mass, was 
capable of normalizing blood glucose level, increasing 
liver glycogen content, and significantly reducing serum 
cholesterol and LDL concentration in alloxan–diabetic rats 
(Nuraliev, Avezov, 1992). Vessal et al. (2003) reported a 
significant increase in the number of pancreatic islets in 
both normoglycemic and diabetic rats treated with quer-
cetin at 10 and 15 mg/kg doses. These authors argued that 
quercetin may act on islet functions, increasing the number 
of pancreatic islets and stimulating insulin release in STZ-
diabetic rats, as well as inducing the hepatic glucokinase 
enzyme in the liver. According to Vessal et al. (2003), the 
increase in hepatic glucokinase activity can be considered 
an indirect indicator of insulin release by β cells. 
In conclusion, these findings suggest a beneficial 
role of the C. xanthocarpa decoct on the diabetic status of 
STZ-treated rats. However, additional pharmacological, 
toxicological and histopathological studies are necessary 
to determine the probable mechanisms of action of C. 
xanthocarpa decoct.
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